Omega Diagnostics Group Plc (ODX):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7873)
◆英語タイトル:Omega Diagnostics Group Plc (ODX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7873
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests for diseases such as renal disease, connective tissue disease and anaemia. Omega offers diagnosis of infectious diseases, including Syphilis, TB and Dengue Fever. The company supplies tests based on agglutination, enzyme immunoassay, fluorescence, rapid and micro-array technologies. It markets its diagnostic kits and systems to hospitals, blood banks, clinics and laboratories. The company operates in the UK, Germany and India. Omega is headquartered in Alva, the UK.

Omega Diagnostics Group Plc (ODX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Omega Diagnostics Group Plc, Medical Equipment, Deal Details 10
Partnerships 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For Syphilis 11
Omega Diagnostics Enters into Distribution Agreement with Immunodiagnostic Systems 12
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 13
Equity Offering 14
Omega Diagnostics Group to Raise USD3 Million in Private Placement of Shares 14
Omega Diagnostics Group to Raise USD1.3 Million in Rights Offering of Shares 15
Omega Diagnostics Group Plc – Key Competitors 16
Omega Diagnostics Group Plc – Key Employees 17
Omega Diagnostics Group Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
May 02, 2018: Omega Diagnostics: Closure of Omega Diagnostics GmbH 19
Financial Announcements 20
Dec 14, 2017: Omega Diagnostics Group:Interim Results for the Six Months Ended 30 September 2017 20
Jun 30, 2017: Omega Diagnostics Group: Final Results For The Year Ended 31 March 2017 23
Corporate Communications 34
Dec 14, 2017: Omega Diagnostics Group: CEO succession 34
Legal and Regulatory 35
Nov 01, 2017: Omega Diagnostics Group: Change of Registered Office 35
Jan 11, 2017: Omega Diagnostics Group: ISO accreditation for manufacturing facility in Pune, India 36
Other Significant Developments 37
Sep 27, 2018: Omega Diagnostics Group: Allergy CE-Mark and first Purchase Order 37
Apr 20, 2018: Omega Diagnostics: Allersys Distribution Agreement 38
Apr 10, 2018: Omega Diagnostics: Strategic Review of operations and Trading Update 39
Oct 16, 2017: Omega Diagnostics Group :Announces US Supply Agreement 41
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Omega Diagnostics Group Plc, Medical Equipment, Key Facts, 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Deals By Market, 2012 to YTD 2018 8
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For Syphilis 11
Omega Diagnostics Enters into Distribution Agreement with Immunodiagnostic Systems 12
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 13
Omega Diagnostics Group to Raise USD3 Million in Private Placement of Shares 14
Omega Diagnostics Group to Raise USD1.3 Million in Rights Offering of Shares 15
Omega Diagnostics Group Plc, Key Competitors 16
Omega Diagnostics Group Plc, Key Employees 17
Omega Diagnostics Group Plc, Other Locations 18
Omega Diagnostics Group Plc, Subsidiaries 18

List of Figures
Omega Diagnostics Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Omega Diagnostics Group Plc (ODX):医療機器:M&Aディール及び事業提携情報(Omega Diagnostics Group Plc (ODX) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆